Leeds's St James's University Hospital and Leeds Teaching Hospitals NHS Trust manage significant Hepatitis C patient populations across West Yorkshire. For Leeds patients facing NHS eligibility hurdles, treatment waiting times, or who are accessing care privately, Resof L offers the same Ledipasvir+Sofosbuvir cure at a fraction of brand Harvoni's private UK cost.
West Yorkshire's large South Asian communities — particularly from Pakistan and Bangladesh where Hepatitis C prevalence is higher — create specific demand for affordable HCV treatment access. Generic Resof L removing cost as a barrier to cure is clinically and socially impactful in Leeds's diverse, multicultural patient population.
Visit medshopy.com or WhatsApp +91 82650 41513 for Leeds and Yorkshire supply.
West Yorkshire's large South Asian communities — particularly from Pakistan and Bangladesh where Hepatitis C prevalence is higher — create specific demand for affordable HCV treatment access. Generic Resof L removing cost as a barrier to cure is clinically and socially impactful in Leeds's diverse, multicultural patient population.
Visit medshopy.com or WhatsApp +91 82650 41513 for Leeds and Yorkshire supply.
Which Hepatitis C genotypes does Resof L (Ledipasvir+Sofosbuvir) treat effectively?Resof L (Ledipasvir+Sofosbuvir) has its strongest clinical evidence and licensing for Hepatitis C Genotypes 1, 4, 5, and 6. Genotype 1 — the most common genotype in the UK, USA, and much of Europe — achieves SVR12 cure rates above 95% with 8 or 12 weeks of treatment depending on patient-specific factors. Genotypes 4, 5, and 6 also respond very well. Genotypes 2 and 3 are better treated with other regimens (Sofosbuvir+Velpatasvir), so your Leeds hepatologist will confirm your genotype before prescribing to ensure Resof L is the optimal choice for your specific infection.
